COMMERCIALISING TARR™

Commercialising the QHeart TARR™

1

The next step is to execute a pilot first-in-man study, before progressing to a clinical trial aiming to secure FDA clearance for the device.

2

QHeart Medical is preparing to execute a Capital Raise to fund clinical trials through to FDA clearance for the QHeart Medical TARR™ device.

3
QHeart has a strong investment proposition:
  • Project significantly de-risked
  • Excellent validation data
  • Fifteen issued & pending patents
  • Represents a revenue opportunity of >US$1B per year
  • An experienced team with a strong track record
  • Clear pathway defined to commercialization and exit